Zhengye Biotechnology Holding Limited Current Cash

Zhengye Biotechnology Holding Limited posts a current cash of $50M as of December 2025. That compares with $19M in the prior-year period — up 170.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Zhengye Biotechnology Holding Limited's current cash was $19M. The latest reading is $50M — a 170.5% year-over-year increase (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Zhengye Biotechnology Holding Limited's financial statement story. At $50M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ZYBT's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Zhengye Biotechnology Holding Limited's other metric pages and overview cover the third.